Piecing Together the Puzzle: Advancements in Autism

Online Via Webinar


9:30am - 12:30am

Autism spectrum disorder (ASD) is a complex developmental disability, typically appearing during childhood and affecting a person’s ability to communicate and form social relationships for their entire life . The US CDC estimates that today ASD affects 1 in 59 children in the United States, and there is currently no approved medication to treat ASD core symptoms . Join Johnson & Johnson Innovation – JLABS, Janssen R&D and CLSA for a short symposium to hear from a patient as they describe their journey managing this challenging disorder, and from top southern California researchers and scientists dedicated to finding potential solutions to better serve patients and families that are affected by ASD.

Special 1-on-1 Opportunity:
Are you developing a potential innovation addressing autism in one of these key areas? Submit a request to meet 1-on-1 with Gahan Pandina, Sr. Director, Neuroscience, Janssen R&D before the program [DEADLINE SEPTEMBER 30th]

• Potential novel MOA treatments for autism core and associated symptoms
• Autism biomarkers – biological, eye tracking, EEG, other sensor-based assessments
• Novel ASD diagnostics
• Web and mobile apps for diagnosis / treatment
• Potential novel behavioral treatments

Click Here for More Information

Contact: Janelle Hunt
Contact Email: